Mediators of Inflammation

Inflammatory and Immune-Mediated Cutaneous Diseases


Publishing date
06 Oct 2017
Status
Published
Submission deadline
19 May 2017

1Universidade Federal do Para, Belem, Brazil

2Sao Paulo University (USP), Sao Paulo, Brazil

3University of Naples Federico II, Naples, Italy


Inflammatory and Immune-Mediated Cutaneous Diseases

Description

The skin is considered to be a complex and immunologically privileged organ. The complex structure of the skin immune system causes various diseases to follow a clinical pattern depending on the immune and local inflammatory response. Autoimmune, infectious, and inflammatory diseases with clinical patterns depending on the interaction between damaging agent and host response pattern are included within this group.

In recent years, increasing attention has been given to the role of other immune cells as adjuvants of this immune-inflammatory response, as well as the role of new cytokine profiles and immune cells in the development of skin diseases. Within this context, the increasing knowledge of cellular and molecular immunology has contributed to a better understanding of the pathogenesis and clinical outcome as well as the specific therapeutic response.

The goal of this special issue is to publish new information on the frontier of knowledge of inflammatory and immune-mediated skin diseases addressing their pathogenic, clinical, immunologic, immunogenetic, molecular, and protein aspects in order to promote a better understanding of the evolution of such diseases.

The issue will have dermatology professionals and immunologists and focus on infectious diseases, internal medicine, molecular biology, and others, thus increasing the reach of publications and the impact on the area of expertise.

Potential topics include but are not limited to the following:

  • Cellular and humoral immunology
  • Imunogenetics
  • Pathogenesis and clinical evolution
  • Imunopathology
  • Genomics and proteomics
  • In situ immune response
  • Immunomodulators and therapeutics
  • Inflammatory disease and cancer

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 6793968
  • - Editorial

Inflammatory and Immune-Mediated Cutaneous Diseases

Juarez A. S. Quaresma | Mirian N. Sotto | Anna Balato
  • Special Issue
  • - Volume 2017
  • - Article ID 7435621
  • - Research Article

HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the Inflammatory/Repair Response of Human Keratinocytes

Irma Colombo | Enrico Sangiovanni | ... | Mario Dell’Agli
  • Special Issue
  • - Volume 2017
  • - Article ID 7215072
  • - Review Article

Contribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis

Isabelle Lorthois | Daniel Asselineau | ... | Roxane Pouliot
  • Special Issue
  • - Volume 2017
  • - Article ID 5217967
  • - Review Article

Advances of Stem Cell Therapeutics in Cutaneous Wound Healing and Regeneration

Suman Kanji | Hiranmoy Das
  • Special Issue
  • - Volume 2017
  • - Article ID 5385102
  • - Research Article

Suppressed Programmed Death 1 Expression on CD4+ and CD8+ T Cells in Psoriatic Patients

Joanna Bartosińska | Ewelina Zakrzewska | ... | Krzysztof Giannopoulos
  • Special Issue
  • - Volume 2017
  • - Article ID 9524594
  • - Research Article

Middermal Elastolysis: Dermal Fibroblasts Cooperate with Inflammatory Cells to the Elastolytic Disorder

Giovanna De Cunto | Arianna Lamberti | ... | Eleonora Cavarra
  • Special Issue
  • - Volume 2017
  • - Article ID 6746870
  • - Review Article

TWEAK/Fn14 Activation Participates in Skin Inflammation

Qilu Liu | Shengxiang Xiao | Yumin Xia
  • Special Issue
  • - Volume 2017
  • - Article ID 4123694
  • - Review Article

Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?

Ilaria Puxeddu | Federico Pratesi | ... | Paola Migliorini
  • Special Issue
  • - Volume 2017
  • - Article ID 7279818
  • - Review Article

Psoriasis and Cardiovascular Risk—Do Promising New Biomarkers Have Clinical Impact?

Sirje Kaur | Külli Kingo | Mihkel Zilmer
Mediators of Inflammation
 Journal metrics
Acceptance rate36%
Submission to final decision53 days
Acceptance to publication29 days
CiteScore6.000
Impact Factor3.758
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.